Upgrade to SI Premium - Free Trial

Bernstein SocGen Reiterates Outperform Rating on Eli Lilly (LLY)

April 21, 2026 7:19 AM
Bernstein SocGen Group analyst Courtney Breen reiterated an Outperform rating and $1,300.00 price target on Eli Lilly (NYSE: LLY).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles